|
C2ORF68 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.744600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.384300E-02 |
| Normal-vs-Stage2 |
3.899900E-02 |
| Normal-vs-Stage3 |
5.50160000000188E-05 |
| Normal-vs-Stage4 |
2.327500E-02 |
| Stage1-vs-Stage2 |
5.326000E-01 |
| Stage1-vs-Stage3 |
9.420600E-03 |
| Stage1-vs-Stage4 |
3.682800E-01 |
| Stage2-vs-Stage3 |
3.080400E-01 |
| Stage2-vs-Stage4 |
8.589600E-01 |
| Stage3-vs-Stage4 |
4.175800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.939850E-03 |
| Normal-vs-AfricanAmerican |
4.833600E-01 |
| Normal-vs-Asian |
3.774000E-01 |
| Caucasian-vs-AfricanAmerican |
1.803830E-01 |
| Caucasian-vs-Asian |
5.251700E-02 |
| AfricanAmerican-vs-Asian |
9.539000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.888200E-02 |
| Normal-vs-Female |
1.420810E-03 |
| Male-vs-Female |
1.492360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.928100E-02 |
| Normal-vs-Age(41-60Yrs) |
7.501500E-03 |
| Normal-vs-Age(61-80Yrs) |
2.920100E-03 |
| Normal-vs-Age(81-100Yrs) |
8.358500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.528600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.112000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.721800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.660800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.471800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.285780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.75670000002182E-06 |
| Classical-VS-Follicular |
1.984400E-01 |
| Classical-VS-Other |
7.271800E-01 |
| Classical-VS-Normal |
3.758100E-02 |
| Tall-VS-Follicular |
3.122500E-03 |
| Tall-VS-Other |
9.012400E-02 |
| Tall-VS-Normal |
2.62130000039384E-07 |
| Follicular-VS-Other |
4.963000E-01 |
| Follicular-VS-Normal |
1.497770E-02 |
| Other-VS-Normal |
6.451600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.137600E-02 |
| Normal-vs-N1 |
5.349600E-02 |
| N0-vs-N1 |
9.537200E-01 |
|
|
